SCHEMBL25077302

SCHEMBL25077302

CCCCCCCCCCCCCCCCCC[C@@H](COP(=O)(O)OC[C@@]1(C)O[C@@H](c2ccc3c(N)ncnn23)[C@H](O)[C@@H]1O)OCc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ POLRMT O00411 1/20 0.46
▸ DOT1L Q8TEK3 1/20 0.33
▸ CETP P11597 3/20 0.31
▸ ADK P55263 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25764487 0.93 POLRMT (0.45) POLRMTDOT1LADK
SCHEMBL25077245 0.93 POLRMT (0.45) POLRMTDOT1LADK
SCHEMBL25768108 0.92 POLRMT (0.43) POLRMTDOT1L
SCHEMBL25077236 0.91 POLRMT (0.45) POLRMTDOT1LCETPADK
SCHEMBL25770226 0.91 POLRMT (0.43) POLRMTDOT1L
SCHEMBL25077136 0.90 POLRMT (0.44) POLRMTDOT1L
SCHEMBL25765070 0.90 POLRMT (0.44) POLRMT
SCHEMBL25077408 0.90 POLRMT (0.38) POLRMT
SCHEMBL25766119 0.90 POLRMT (0.42) POLRMT
SCHEMBL25768155 0.89 POLRMT (0.43) POLRMTDOT1L

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230212199-A1 PHOSPHOLIPID COMPOUNDS AND METHODS OF MAKING AND USING THE SAME GILEAD SCIENCES, INC. 2023-07-06 — — US disclosed
WO-2023023527-A1 PHOSPHOLIPID COMPOUNDS AND METHODS OF MAKING AND USING THE SAME GILEAD SCIENCES, INC. (US) 2023-02-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230212199-A1 PHOSPHOLIPID COMPOUNDS AND METHODS OF MAKING AND USING THE SAME PHOSPHO1, SGMS1, SGMS2 POLRMT 266/4885DOT1L 2986/4885CETP 67/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback